© 2022 WUKY
background_fid.jpg
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations

This week on Dr. Greg: a preview of UK's upcoming Substance Use Research Event

Ways To Subscribe
HillarySuratt
UK Now
/

The annual Substance Use Research Event (SURE), formerly known as Substance Use Research Day, showcases the translational research conducted at the University of Kentucky focusing on substance use and substance use disorder. Dr. Greg gets a preview from Hilary Surratt, associate professor in the Center for Health Services Research and the Department of Internal Medicine at the University of Kentucky College of Medicine.

The event is free and open to all members of the UK and the greater Lexington community who are interested in the field. Its sponsored by the University of Kentucky Office of the Vice President for Research and features prominent keynote speakers, as well as breakout sessions that cover cutting-edge topics in the field.

The 2022 event is scheduled for March 1st in the UK Gatton Student Center. Our keynote speakers are Dr. Jacqueline McGinty from the University of South Carolina and Dr. Ricky Bluthenthal from the Keck School of Medicine, University of Southern California.

https://www.research.uky.edu/SURE

Hilary Surratt is associate professor in the Center for Health Services Research and the Department of Internal Medicine at the University of Kentucky College of Medicine. She has expertise in the areas of illicit and prescription drug misuse, prescription drug diversion and drug-related HIV infection. Her work has included the development and evaluation of behavioral HIV and HCV interventions for vulnerable substance using populations in community settings, as well as epidemiologic studies of prescription drug diversion, including opioid analgesics and antiretroviral medications. She has served as Principal Investigator (PI) or Co-Investigator on more than 12 National Institutes of Health (NIH)-funded studies. Her current research focuses on the examination of syringe service programs in Kentucky and the development of targeted interventions to link people who inject drugs to substance use treatment.